Values First Advisors’s Zymeworks ZYME Stock Holding History

Values First Advisors’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,149	Closed	-$28.5K	–	351
2023 Q1	$28.5K	Buy	+3,149	New	+$27.5K	0.02%	207
2022 Q4	–	Sell	-16,998	Closed	-$105K	–	167
2022 Q3	$105K	Sell	16,998 -1,142	-6%	-$6.88K	0.08%	143
2022 Q2	$96K	Buy	18,140 +2,205	+14%	+$13.3K	0.07%	144
2022 Q1	$104K	Buy	+15,935	New	+$142K	0.07%	151
2021 Q4	–	Sell	-7,072	Closed	-$205K	–	176
2021 Q3	$205K	Buy	+7,072	New	+$235K	0.13%	136

Other funds holding ZYME

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Values First Advisors's ZYME Position: Q2 2023 in Review

Values First Advisors sold out of Zymeworks (ZYME) in Q2 2023, closing a stake of 3,149 shares — an estimated $28.5K sold.

Values First Advisors first reported a position in ZYME in Q3 2021 and held it in 5 quarters. The position peaked at $205K in Q3 2021. 137 funds tracked by Wall St. Rank hold ZYME as of Q2 2023.

Values First Advisors reported no remaining Zymeworks position as of Q2 2023 after selling out during the quarter.
Values First Advisors sold 3,149 Zymeworks shares in Q2 2023, an estimated $28.5K.
Values First Advisors first reported a position in Zymeworks in Q3 2021 and held it in 5 quarters.
Values First Advisors's Zymeworks position peaked at $205K in Q3 2021.
137 funds tracked by Wall St. Rank held Zymeworks as of Q2 2023.

Based on Values First Advisors's 13F filing for Q2 2023, filed 2 Aug 2023.